Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders (Q43041150)
Jump to navigation
Jump to search
scientific article published on 30 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders |
scientific article published on 30 January 2012 |
Statements
1 reference
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders (English)
1 reference
Kazuaki Chayama
1 reference
Shoichi Takahashi
1 reference
Hiromitsu Kumada
1 reference
Kenji Ikeda
1 reference
Joji Toyota
1 reference
Yoshiyasu Karino
1 reference
Hiroki Ishikawa
1 reference
Hideaki Watanabe
1 reference
Fiona McPhee
1 reference
Eric Hughes
1 reference
30 January 2012
1 reference
1 reference
55
1 reference
3
1 reference
742-748
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference